Selvax Cancer Immunotherapy | The Selvax Team
page-template,page-template-full_width,page-template-full_width-php,page,page-id-143,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.2,wpb-js-composer js-comp-ver-5.3,vc_responsive

The Selvax Team

Ron Wise


Ron has a PhD in immunology from UWA and undertook postdoctoral research at Stanford University. He is co founder and Chairman of Selvax and is a major shareholder in the company.

Tony Fitzgerald


Tony is a co founder of Selvax. He practiced law before moving into the life sciences sector where he has undertaken numerous technology licensing and collaborative research transactions and company start ups.

Russell Nicholls


Russell is Deputy Director, IP Commercialisation at Curtin University. He is a registered technology transfer professional and graduate of the Australian Institute of Company Directors.

Delia Nelson BSc PhD

Chief Scientific Officer

Delia is a Professor in the School of Pharmacy and Biomedical Sciences at Curtin University. She has over twenty years research experience in tumour immunology and ageing and is a co founder of Selvax.

Stephen Proksch BSc MBA

Research Coordinator

Stephen is a biomedical research scientist and MBA graduate with over ten years experience working in the biotechnology sector. His major areas of expertise are immunology and molecular genetics.

Nandini Makwana BSs PhD

Research Scientist

Nandini has a PhD from the University of West Australia. She is experienced in running clinical-based research projects, and has specialist expertise in the design of cell-based assays.